Natera Reports Strong Advanced Adenoma Data from Prospective PROCEED-CRC Trial, Demonstrating 22.5% Sensitivity and 91.5% Specificity

Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA and precision medicine, today announced another successful ...
Healio

Next-generation Cologuard demonstrates improved colorectal cancer sensitivity, specificity

Next-generation Cologuard exhibited improved colorectal cancer specificity and sensitivity compared with results of the FDA registrational trial that led to approval of the noninvasive screening test, ...
Business Wire

Universal DX Presents Data from Large, 1,000-patient, Multi-Cohort Study Proving 91% Sensitivity for Colorectal Cancer and 54% Sensitivity for Advanced Adenoma at 92% Specificity

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Universal Diagnostics (Universal DX), a bioinformatics and multi-omics company on a mission to transform cancer into a curable disease, today announced the results ...
MedPage Today

Blood-Based Test for CRC Screening Hits Sensitivity, Specificity Endpoints

WASHINGTON -- A blood-based test for the early detection of colorectal cancer (CRC) met its prespecified sensitivity and specificity endpoints, according to results from the PREEMPT CRC study. Using ...
2 Minute Medicine

Artificial intelligence (AI) may reduce cognitive load for sonographers in fetal ultrasound scans without affecting diagnostic performance

Day and colleagues randomized sonographers to scan pregnant participants with AI assistance or the standard method for ...
The Scientist

Insights into qPCR: Protocol, Detection Methods, and Analysis

Quantitative polymerase chain reaction (qPCR) is a molecular technique that has reshaped the landscape of biological research and medicine due to its high sensitivity and specificity. qPCR, also known ...